Search for: "Lange v. Andrews"
Results 21 - 40
of 131
Sort by Relevance
|
Sort by Date
27 Dec 2023, 5:51 am
Let the games commence… More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Artificial Intelligence and Patents: An International Perspective on Patenting AI-Related Inventions by Jonathan P. [read post]
8 Dec 2023, 5:35 am
The facts of the case On 21 November 2023, Sir Anthony Mann of the London High Court handed down a judgment in the case of Emotional Perception AI Ltd v Comptroller-General of Patents, Designs and Trade Marks [2023] EWHC 2948 (Ch). [read post]
4 Dec 2023, 7:14 am
Thus, with its order of July 11, 2023, it allowed an appeal to proceed (see case C-93/23, EUIPO v Neoperl). [read post]
27 Nov 2023, 2:08 am
For example, in Rosalba Alassini v. [read post]
23 Nov 2023, 1:42 am
In so doing, the court relied on the Division Bench[1]Novartis AG v. [read post]
17 Nov 2023, 6:00 am
Multiple parallel cases This was an interesting feature of the Ocado v AutoStore litigation. [read post]
14 Nov 2023, 4:18 am
On 25 October 2023, HHJ Hacon (sitting as a High Court Judge), rendered his judgment in Philip Morris v Nicoventures[1]. [read post]
3 Nov 2023, 7:15 am
The starting point for Mellor J’s analysis was Kitchin LJ’s judgment in Regeneron v Genentech [2013] EWCA Civ 93. [read post]
23 Oct 2023, 2:56 am
The same principle was affirmed in November 2020 in Philips v. [read post]
17 Oct 2023, 3:40 pm
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eig [read post]
20 Sep 2023, 7:13 am
’ More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 Patent Litigation Through the Unified… [read post]
20 Sep 2023, 7:13 am
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 Patent Litigation Through the Unified Patent Court… [read post]
19 Sep 2023, 8:32 am
Wyeth LLC v. [read post]
5 Sep 2023, 6:14 am
Any error in the Board’s claim construction was harmless and substantial evidence, including the claim language and expert testimony, supported the Board’s findings of motivation to combine (Bot M8 LLC v. [read post]
26 Aug 2023, 9:16 am
Protective letters In the case MyStromer v Revolt Zycling (UPC_CFI_177/2023) the UPC’s local division in Düsseldorf ordered a preliminary injunction, despite the fact that Revolt had filed a protective letter. [read post]
25 Aug 2023, 1:29 am
The board’s claim construction and motivation to combine analysis were supported by the record (Shamoon v. [read post]
2 Aug 2023, 2:14 am
On 25 July 2023, the Court of Appeal handed down its decision in Teva & Sandoz v Astellas[1] concerning the validity of Astellas’ patent to mirabegron for use in the treatment of overactive bladder (“OAB”). [read post]
30 Jul 2023, 3:05 am
Country of origin: new European applications in 2022 v requests for unitary effect On the other hand, proprietors from Asia and the US appear overall less enthusiastic relative to their proportion of European filings. [read post]
26 Jul 2023, 1:53 am
In Sun Pharma v. [read post]
25 Jul 2023, 1:43 am
Or that the credibility of the technical effect is assessed at the priority or filing date (e.g., TGI Paris, October 6, 2009, RG n°07/16446, Teva v. [read post]
